0001209191-17-013940.txt : 20170223 0001209191-17-013940.hdr.sgml : 20170223 20170223173810 ACCESSION NUMBER: 0001209191-17-013940 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170223 DATE AS OF CHANGE: 20170223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Went Gregory T CENTRAL INDEX KEY: 0001604541 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 17633889 MAIL ADDRESS: STREET 1: C/O ADAMAS PHARMACEUTICALS, INC. STREET 2: 2200 POWELL ST, STE 220 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-21 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001604541 Went Gregory T C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 1 1 0 0 Chief Executive Officer Common Stock 2017-02-21 4 A 0 23125 0.00 A 169333 D Common Stock 195392 I By Trust Common Stock 80000 I Gregory T. Went & Marjorie S. Went ttees 2012 Irr Trust FBO Bridget Elise Went Common Stock 80000 I Gregory T. Went & Marjorie S. Went ttees 2012 Irr Trust FBO Cora Margaret Went Stock Option (Right to Buy) 17.20 2017-02-21 4 A 0 138750 0.00 A 2027-02-20 Common Stock 138750 138750 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2018, March 20, 2019, March 20, 2020 and March 20, 2021, subject to Reporting Person's Continuous Service as of each such date. The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2017, subject to Reporting Person's Continuous Service as of each such date. /s/Jennifer Rhodes, as Attorney-in-Fact 2017-02-23